Abstract | Recent studies have highlighted the importance of the human microbiome in health and disease. However, for the most part the mechanisms by which the microbiome mediates disease, or protection from it, remain poorly understood. The keystone-pathogen hypothesis holds that certain low-abundance microbial pathogens can orchestrate inflammatory disease by remodelling a normally benign microbiota into a dysbiotic one. In this Opinion article, we critically assess the available literature that supports this hypothesis, which may provide a novel conceptual basis for the development of targeted diagnostics and treatments for complex dysbiotic diseases.
In architecture, the keystone is the central supporting stone at the apex of an arch. The term keystone has been introduced in the ecological literature to characterize species that have disproportionately large effects on their communities, given their abundance, and that are thought to form the 'keystone' of the community's structure [1] [2] [3] . Although this term was originally applied to a top predator (the starfish Pisaster ochraceus) in the rocky intertidal zone 2, 4 , the keystone concept has been extended to species across different trophic levels and has been categorized to reflect specific functions. For instance, beavers exert keystone effects on their ecosystem by engineering the environment (making them keystone modifiers), whereas certain plants have an impact on the ecosystem by supporting pollinators and seed dispersers (making them keystone hosts) 2 . The influence of keystone species contrasts with that of dominant species, which are the major energy transformers in an ecosystem and thus influence it by virtue of their large biomass.
If keystone species can be identified in microbial ecology, this could yield enhanced insights into the structure of microbial communities and the interplay with their hosts or environment. In humans, given the central importance of the microbiome in health and disease, there is currently great interest in elucidating both the mechanisms that maintain host-microorganism homeostasis at mucosal surfaces and the mechanisms that disturb this homeostatic balance, leading to dysbiosis (that is, a change in the relative abundance of individual microbiota components compared with their abundance in healthy individuals) and the initiation of inflammatory disease [5] [6] [7] [8] [9] [10] . A keystone microorganism that supports and stabilizes the dysbiotic microbiota associated with a disease state is referred to here as a keystone pathogen. Importantly, the capacity of keystone pathogens to instigate inflammation even when they are present as quantitatively minor components of the microbiota is in stark contrast to the inflammation induced by dominant pathogens, which become established as the dominant components of the microbiota while simultaneously causing suppression of the commensal organisms 11 (FIG. 1) .
The identification of keystone pathogens could also have substantial clinical benefits, as it may facilitate the development of novel treatments for polymicrobial or complex dysbiotic diseases by focusing therapeutic strategies on only a limited number of bacterial targets that stabilize the dysbiotic microbial community. Moreover, novel targeted diagnostic tools could be developed if a complex polymicrobial disease is shown to be driven by a keystone pathogen or by a limited number of microorganisms acting in this manner.
This Opinion article aims to discuss and critically assess the available evidence regarding the possible presence of keystone or keystone-like pathogens in the human microbiota and their role in disease. This evidence has been derived mainly from experimental animal models of disease (periodontitis, inflammatory bowel disease, colon cancer and obesity) and is consistent with data derived from studies in humans. In our opinion, the literature is supportive of the keystone-pathogen hypothesis and warrants further research in the quest to identify microorganisms that exert an inordinately large and adverse impact on host-microorganism homeostasis.
Periodontitis and dysbiosis
Periodontitis is a biofilm-induced chronic inflammatory disease which affects the tooth-supporting tissues, or periodontium 12 , and also increases a patient's risk of developing atherosclerosis, diabetes and possibly rheumatoid arthritis [13] [14] [15] . Although the tooth-associated biofilm plays a crucial role in the initiation and progression of periodontitis, it is primarily the host inflammatory response that inflicts the irreversible damage on the periodontium, leading to tooth loss in some cases 16, 17 . Early bacteriological studies revealed dramatic differences in the composition of the periodontal microbiota in health versus in disease 18, 19 . This shift in bacterial community composition could be interpreted in two ways. First, it could be taken as a sign that specific bacteria are involved in the aetiology of periodontitis, in that the disease-associated microbiota contains novel species -or periodontal pathogens -that are either not present or barely detectable in the healthy state. Second, it could imply that the disease is caused by dysbiosis of the perio dontal microbiota, leading to alterations in host-microorganism crosstalk that are of sufficient magnitude to initiate inflammatory disease.
There has been significant progress in the quest to identify specific periodontal pathogens, including the identification of several candidates, mostly Gram-negative anaerobic bacteria that colonize subgingival tooth sites. Foremost among this group are three species that constitute the so-called red complex, are frequently isolated together and are strongly associated with 20 , Treponema denticola and Tannerella forsythia 21, 22 . Much research has been directed towards understanding the pathogenic mechanisms and virulence determinants of these three bacterial species in the context of a conventional hostpathogen interaction, as exemplified by diseases with a single-infective aetiology 21 . Support for the alternative hypothesis, that periodontal pathogens transform the normally symbiotic microbiota into a dysbiotic state which leads to a breakdown in the normal homeostatic relationship with the host, comes from evidence that P. gingivalis has evolved sophisticated strategies to evade or subvert components of the host immune system (for example, Toll-like receptors (TLRs) and complement) rather than acting directly as a pro-inflammatory bacterium (reviewed in REFS 9, 23, 24) . Accordingly, it was hypothesized that P. gingivalis impairs innate immunity in ways that alter the growth and development of the entire biofilm, triggering a destructive change in the normally homeostatic host-microbiota interplay in the periodontium. In other words, P. gingivalis could be a keystone pathogen of the diseaseprovoking periodontal microbiota.
The keystone hypothesis is supported by a recent study in the mouse model. This study showed that, at very low colonization levels (<0.01% of the total bacterial count), P. gingivalis induces periodontitis accompanied by significant alterations in the number and community organization of the oral commensal bacteria 25 (FIG. 1a) .
These alterations occur soon after P. gingivalis colonization and precede the onset of inflammatory bone loss, suggesting that the dysbiosis is the cause of the disease. The obligatory participation of the commensal microbiota in disease pathogenesis was shown by the failure of P. gingivalis alone to cause perio dontitis in germfree mice, despite its ability to colonize this host 25 . P. gingivalis fails to cause dysbiosis and periodontitis in conventional mice when the mice lack the cellular receptors necessary for the bacterium to subvert leukocyte defences, or when the bacterium lacks a crucial enzymatic activity involved in leukocyte subversion 25, 26 . In this regard, the arginine-specific cysteine proteinases (gingi pains) of P. gingivalis exhibit complement C5 convertase-like activity, generating high levels of C5a locally to activate C5a receptor (C5aR) on leukocytes (FIG. 1a) . C5aR signalling is involved in crosstalk with TLR2, which is activated in parallel by P. gingivalis surface ligands, and this crosstalk leads to enhanced inflammation but an impaired killing capacity for leukocytes 26, 27 . P. gingivalis might additionally prevent the activation of TLR4-dependent antimicrobial pathways in leukocytes by expressing an atypical lipopolysaccharide with a 4-acyl-monophosphorylated lipid A moiety that is a potent antagonist of TLR4 (REF. 9 ). P. gingivalis can also use a secreted serine phosphatase (SerB) to inhibit the synthesis of interleukin-8 (IL-8) by epithelial cells, thus delaying the recruitment of neutrophils and facilitating the initial colonization of the periodontium [28] [29] [30] . The synthesis of IL-8 by the junctional gingival epithelium, adjacent to the tooth surface, is thought to be an important feature of the healthy periodontium because it generates a gradient for recruitment of neutrophils into the gingival crevice.
The subversion of recruited leukocytes by wild-type P. gingivalis may allow uncontrolled growth of other species in the same biofilm, consistent with the observed elevation of the total bacterial count following P. gingivalis colonization of the mouse periodontium 25 . Moreover, uncontrolled bacterial growth leads to enhanced complement-dependent destructive inflammation, which generates abundant tissue-breakdown products, including degraded proteins and hemin, that serve the nutritional needs of the bacteria (FIG. 2) . This may fuel further changes to the biofilm and stabilize the transition to a disease-provoking microbiota. The inflammation-mediated environmental changes can be exploited by proteolytic and asaccharolytic bacteria (that is, those organisms which are associated with periodontal disease rather than health) 9 . Those species that cannot benefit from the nutrients present in the inflammatory exudate, or for which host inflammation is detrimental, may have a fitness disadvantage and, hence, be outcompeted or eliminated.
Although P. gingivalis exerts a keystone effect via host modulation (FIG. 2) , one cannot rule out the possibility that this pathogen also modulates the commensal oral microbiota through host-independent, direct effects. Metatranscriptomic analysis of oral microbial communities has shown that the introduction of P. gingivalis into a healthy multispecies biofilm alters the pattern of community gene expression (for example, causing upregulation of chaperones, ABC-transport systems, putative transposases, and proteins related to growth and division, as well as numerous transcription factors) 31 . The keystone-pathogen concept was initially established in the mouse model, but it is consistent with observations in other animal models of periodontitis. In rabbits, P. gingivalis causes a shift to a more anaerobic microbiota in the dental biofilm and an overall increase in bacterial load 32 . In non-human primates, a reduction in the number of indigenous P. gingivalis cells, as a result of specific immunization with a gingipain-based vaccine, is accompanied by a reduction in the total subgingival bacterial load and protection against bone loss 33 . The keystone concept is furthermore consistent with P. gingivalis being a quantitatively minor constituent of human periodontitisassociated biofilms 18, 34, 35 , despite its high prevalence and association with progressive bone loss in periodontitis patients 36, 37 . Importantly, specific removal of P. gingivalis from the periodontal biofilm (by means of a C5aR antagonist) reverses the dysbiotic changes 25 (FIG. 1a) , indicating that dysbiotic diseases could be treated by specific targeting of keystone pathogens.
Intestinal inflammatory diseases
The commensal microbiota is thought to play a part in the development of inflammatory bowel diseases (IBD) 6, 8, 38, 39 . A commensal microbiota-dependent model of ulcerative colitis was recently developed in mice lacking Tbet (also known as Tbx21; encoding the transcription factor TBET) and Rag2 (encoding V(D) Figure 2 | Porphyromonas gingivalis-induced dysbiosis and periodontal disease. Porphyromonas gingivalis subverts complement (step 1) and impairs host defence (step 2), leading to overgrowth of oral commensal bacteria, which causes complement-dependent inflammation (steps 3 and 4). Inflammatory tissue destruction (step 5) is favourable to further bacterial growth, as it provides a nutrient-rich gingival inflammatory exudate (containing degraded host proteins and hemin, a source of essential iron). These environmental changes are well exploited by, and thus favour, proteolytic and asaccharolytic bacteria, leading to compositional changes in the bacterial community. Moreover, inflammatory bone resorption (step 6) provides the dysbiotic microbiota with new niches for colonization (step 7). These alterations collectively lead to and sustain periodontal disease. Numbers indicate a possible sequence of events that sets off a self-feeding 'vicious cycle'.
J recombination-activating protein 2 (RAG2)), and is known as the TRUC model 40 . In these mice, the absence of adaptive immunity (caused by the lack of RAG2) combined with the lack of TBET results in spontaneous colitis, which is transmissible to co-housed wild-type mice and is characterized by compromised colonic barrier function, dysfunctional dendritic cells and elevated levels of tumour necrosis factor (TNF) 40 . It is thought that TBET has a role in maintaining a homeostatic relationship between the host and the microbiota; loss of TBET expression in colonic dendritic cells causes aberrant TNF responses that drive tissue injury and compromise colonic epithelial barrier function, and this damage precedes the initiation of colitis 40 . Colitis in TRUC mice correlates strongly with the presence of Klebsiella pneumoniae and Proteus mirabilis, the combination of which induces the disease state even in specific-pathogen-free wild-type mice; hence, the ability of these species to instigate disease does not require a host with altered immune function 41 . Strikingly, the combination of K. pneumoniae and P. mirabilis cannot by itself induce colitis when administered to germ-free TRUC mice, suggesting that their colitogenic effect is strictly dependent on the indigenous microbial community. Although K. pneumoniae and P. mirabilis can co-colonize germ-free mice at high levels (each at ≥10 11 colonyforming units (cfu) per gram faeces), they constitute <1% of the total faecal microbiota (10 7 -10 9 cfu per gram faeces) of TRUC mice or of infected wild-type mice (that is, specific-pathogen-free wild-type mice that have been infected with the two bacteria), which, as mentioned above, develop colitis after inocu lation with these two Enterobacteriaceae species 41 . This study in the TRUC model 41 supports the proposal that IBD is caused not by individual pathogens, but rather by an entire microbial community under the influence of specific organisms that can tip the balance from homeostasis to destructive inflammation. Thus, the colitogenicity of two low-abundance species, K. pneumoniae and P. mirabilis, requires the endogenous gut microbiota, and colitis in TRUC mice is characterized not only by the presence of these two species but also by a dysbiotic gut microbiota that is quantitatively and qualitatively different from that of healthy controls. These two facts together suggest that K. pneumoniae and P. mirabilis act as keystone pathogens in a mode similar to that of P. gingivalis in periodontitis. However, whether K. pneumoniae and P. mirabilis affect the number of bacteria in and/or the composition of the endogenous microbiota in order to elicit the colitogenic effect has not yet been addressed, and one cannot exclude the possibility that the role of the commensal microbiota in this IBD model is the induction (or priming) of immunological processes that facilitate destructive inflammatory responses to K. pneumoniae and P. mirabilis. 42, 43 . In terms of quantitative changes, one study has observed overgrowth of members of the family Enterobacteriaceae and a significant reduction in the total number of intestinal bacteria owing to preferential elimination of a subset of the indigenous microbiota (the CFB group, comprising members of the genera Cytophaga, Flavobacterium and Bacteroides) 42 . An independent study using a similar C. rodentium infection model has observed increased abundance of species from the phyla Deferribacteres, Tenericutes and Proteobacteria, whereas the abundance of bacteria from the family Lactobacillaceae, which are thought to ameliorate intestinal inflammation, was reduced 43 . In the same study, C. rodentium was found to constitute 2.8% of the total count in the caecum tissue and 0.23% of its luminal content 43 . Despite there being some differences in the observed changes in microbiota composition, the results of both studies suggest that C. rodentium causes global changes in microbial community structure 42, 43 and that these changes are apparently dependent on the ability of this pathogen to cause inflammation 42 . C. rodentium-induced colitis in mice is transient, and the altered microbiota returns to its normal state following resolution of the infection 4 weeks after the initial inoculation 42, 43 . In fact, the C. rodentium load in infected wild-type mice starts to decline 2 weeks after the initial inoculation 43, 44 , although in immunocompromised mice, which develop severe disease and succumb to the infection, the load continues to rise by ~100-fold, reaching ~10 10 cfu per gram colon content; this is at least 3 logs higher than the load present in wild-type mice at the same time point in infection 44 . Under immunocompromised conditions, therefore, this attaching-and-effacing bacterium appears to act more like a dominant pathogen. By contrast, in infected wild-type mice, the relatively low level (2.8% of the total count) of C. rodentium 43 suggests that it acts as a keystone pathogen. However, it remains to be proved whether, and to what extent, the C. rodentium-induced changes to the gut microbiota contribute to the inflammatory pathology. It is possible that the C. rodentiuminduced changes to the intestinal microbiota occur as a result of, rather than being the cause of, intestinal inflammation 42 . In this regard, chemical induction of gut inflammation by administration of dextran sodium sulphate leads to a dysbiotic microbiota 42 , suggesting an intimate relationship between the inflammatory status of the intestine and the gut microbiota.
Infection of mice with
Until recently, the predominant view of the relationship between the gut microbiota and the inflammatory status of the intestine was that dysbiosis was a consequence rather than a cause of increased inflammation. In addition to the findings in TRUC mice 40, 41 , other studies by independent groups pose further challenge to this traditional notion. Reduced production of IL-18 by colonic epithelial cells in mice deficient for the NLRP6 inflammasome leads to a dysbiotic microbiota (characterized by over-representation of members of the family Prevotellaceae and those of the candidate division TM7, and under-representation of species in the genus Lactobacillus, phylum Firmicutes), which in turn upregulates expression of CC-chemokine ligand 5 (CCL5) and recruits inflammatory cells, leading to spontaneous inflammation 45 . The colitogenic activity of this altered microbiota can be transferred to cross-fostered neonatal or co-housed adult wild-type mice 45 . Moreover, TLR5-deficient mice exhibit features of metabolic syndrome (including hyperlipidaemia, hypertension, insulin resistance and obesity) that correlate with an altered gut microbiota, and the microbiota from these mice is necessary and sufficient to transfer the metabolic syndrome phenotype to germ-free mice, perhaps through chronic low-grade inflammatory signalling 46 . The studies described above have demonstrated that transfer of a dysbiotic gut microbiota from a genetically compromised animal into a healthy, normal recipient animal can reproduce the disease phenotype. This finding is leading to a re-evaluation of the relationship between dysbiosis and inflammation in the gut. Even if dysbiosis of the gut microbiota is not involved in initiating colitis, it could still have a role in maintaining the inflammatory pathology. Colon cancer and the 'alpha-bug' hypothesis Infection-driven chronic inflammation can promote carcinogenesis in the affected tissues or organs. For example, chronic infection with Helicobacter pylori is a major cause of gastric cancer, and chronic infection with hepatitis B virus or hepatitis C virus can lead to liver cancer 47 . In these and certain other types of cancer, including cervical cancer (caused by human papillomavirus), Burkitt's lymphoma (caused by Epstein-Barr virus) and urinary bladder cancer (caused by Schistosoma haematobium), the oncogenic risk is defined by a specific pathogenic organism. By contrast, colon cancer has not been linked to an individual microorganism, although the colonic microbiota is required for induction of chronic colitis and colon cancer, as shown in experiments using germfree mice 48 . Some studies suggest that the triggering of colon cancer may involve the action of multiple members of the colonic microbiota, in combination with risk factors associated with diet and host genetics 49, 50 . Recently, it has been proposed that certain pro-oncogenic bacteria, which are dubbed 'alpha-bugs' and possess unique virulence traits, trigger colon cancer by co-opting and collaborating with the colonic microbiota 51 (FIG. 3) .
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The alpha-bug hypothesis is based on studies with Bacteroides fragilis 52 . Although this species is a constituent of the normal intestinal microbiota, the bacterium can cause serious disease as an opportunistic pathogen. It is a frequent anaerobic isolate from clinical specimens (accounting for >80% of the infections caused by Bacteroides spp.), despite constituting only ~ 0.3% of all the Bacteroides spp. in the colon and <1-2% of the cultured faecal microbiota 53, 54 . 52 . These differential effects of ETBF and NTBF suggest that the capacity of ETBF to secrete BFT is crucial for carcinogenesis, although it should be noted that NTBF expresses polysaccharide A, a symbiosis factor that suppresses T H 17 type pro-inflammatory responses in the gut 56, 57 ( FIG. 3) .
Nevertheless, BFT appears to be a prooncogenic and pro-inflammatory bacterial toxin in its own right. Indeed, BFT indirectly stimulates cleavage of E-cadherin, thereby disrupting intercellular adhesion and compromising the barrier function of the epithelium. Cleavage of E-cadherin by BFT also triggers β-catenin-mediated nuclear signalling, leading to MYC expression and persistent proliferation of human colonic epithelial cells (HT29/C1 cells) 58 . Moreover, in colonic epithelial cells (HT29 cells), BFT activates nuclear factor-κB-dependent expression of chemokines that stimulate transepithelial migration of neutrophils 59 . These activities might play a contributory part in IBD and oncogenic transformation in the colon.
Antibiotic treatment of ETBF-colonized Min mice can change the carcinogenesis rate 51 . Because this treatment modifies the colonic microbiota without interfering with ETBF colonization, it seems that the interactions between ETBF and the microbiota can modulate the outcomes of colon carcinogenesis 51 . However, it is uncertain at present exactly how ETBF affects or interacts with the colonic microbiota to promote carcinogenesis. One possibility is that, by inducing T H 17 cell-mediated inflammation, ETBF modifies the intraluminal environment in a manner that alters the colonic microbiota and its oncogenic potential. In addition, these inflammatory environmental changes toxin (BFT) ), the participation of the colonic microbiota is necessary for colon carcinogenesis. According to the 'alpha-bug' hypothesis, ETBF remodels the colonic microbiota and co-opts this microbial community to induce colon cancer; however, in order for this dysbiosis to trigger tumorigenesis, it is likely that ETBF must be present in combination with particular disease modifiers and in hosts with certain genetic traits. It is currently unclear exactly how ETBF influences and interacts with the colonic microbiota to promote carcinogenesis. Moreover, it is uncertain whether the microbiota is modulated by T H 17 type inflammation or, conversely, contributes to the induction of this immune response. Hypothetical connections are indicated by dashed arrows. might selectively suppress the growth of cancer-protective bacterial species. Alternatively, the microbiota might be a crucial contributory factor for ETBF-induced T H 17 type responses (FIG. 3) . It is also possible that changes to the local microenvironment, as a result of the growing tumour, cause a new selective pressure and further microbial community alterations that can influence the outcome of colorectal cancer progression 60 . The postulated 'alpha' role of ETBF strains in animal models and the low abundance of these bacteria (<1-2% of the colonic microbiota) 51 suggest that ETBF is a keystone pathogen in colon tumorigenesis. Although B. fragilis has been epidemiologically associated with colon cancer in humans 61 , it is not known at present whether this bacterium can remodel the human gut microbiota in ways that promote inflammation and colonic epithelial cell transformation, as postulated by the alpha-bug hypothesis. Nevertheless, recent genomic analysis of the microbiome of human colorectal cancer cells revealed a significant enrichment of Fusobacterium spp. and a depletion of species from the phyla Bacteroidetes and Firmicutes (most notably, members of the class Clostridia) relative to their levels in normal colon tissue 62, 63 . It is currently unclear whether all ETBF strains can induce experimental colon tumours or whether the disease is specific to certain BFT isotypes. From a translational viewpoint, if ETBF is a keystone pathogen in human colon oncogenesis, it might be possible to develop new diagnostic tools (perhaps that can detect the specific BFT isotype) to identify individuals at high risk of colon cancer 51 . Such a translational approach might have to include other potential alpha-bugs, which may have specific virulence traits and modes of action that endow them with similar leading roles in colon tumorigenesis, such as attaching-and-effacing E. coli 64, 65 . In this regard, E. coli strains possessing the pks genomic island (responsible for expression of colibactin, a polyketide-peptide genotoxin) cause DNA damage to enterocytes in vivo, followed by cell division with incomplete DNA repair, thereby potentially contributing to colorectal cancer development 66 .
Major functions by minor members
Methanogenic archaea are minor components of the gut microbiota. However, their ability to reduce small organic compounds (such as carbon dioxide, acetic acid, formic acid and methanol) into methane in the presence of molecular hydrogen (H 2 ) has significant consequences 67 . The removal from the gut of excess hydrogen through methanogenesis prevents the inhibition of bacterial NADH dehydrogenase, thereby leading to an increased yield of ATP from bacterial metabolism and a greater harvest of energy from the diet. Methanogenesis is not the only microbial mechanism to remove excess hydrogen from the gut: this can also be mediated through the reduction of sulphate to sulphide by sulphate-reducing bacteria. However, methanogens appear to outcompete sulphate-reducing bacteria for hydrogen in the human colon 68 . In comparison to methanogens that do not colonize the intestine, the gut-dwelling Methanobrevibacter smithii shows significant enrichment for genes involved in the utilization of carbon dioxide, molecular hydrogen and formate for methanogenesis. It also encodes genes that are probably involved in acetate assimilation and the use of methanol and ethanol 69 . These features suggest that M. smithii can remove a variety of bacterial metabolic end products, an action that may be conducive for syntrophic metabolism with diverse gut microorganisms. M. smithii could thus be important in stabilizing gut microbial communities and appears to be a good example of a "low-abundance microorganism with abundant functions" (REF. 70 ). Moreover, M. smithii displays an enriched repertoire of glucosyltransferase genes (relative to other sequenced non-gut methanogens), which endows this archaeon with great flexibility in decorating its surface with glycans. Strikingly, these archaeal surface glycans mimic those present in the gut mucosa and may thus serve to prevent the activation of host immune responses and inflammation 69 . However, the ability of M. smithii to improve the efficiency of bacterial fermentation of dietary polysaccharides might also have adverse effects. M. smithii was shown to promote host adiposity in experiments in gnotobiotic mice co-colonized with this archaeon and Bacteroides thetaiotaomicron 71 . Moreover, the presence of M. smithii enhances the bacterial digestion of dietary glycans by influencing the transcriptional profile of B. thetaiotaomicron; the most robust response was the induction of several fructofuranosidases, resulting in increased utilization of otherwise inaccessible fructans. The substitution of M. smithii with the sulphatereducing bacterium Desulfovibrio piger, in a similar co-colonization experiment, did not significantly affect the B. thetaiotaomicron transcriptome or host adiposity 71 . In this context, M. smithii could be regarded as a keystone pathogen, as it is a minor constituent of the gut microbiome and can direct bacterial metabolism in ways that promote host adiposity. Whether M. smithii remains at low colonization levels in obese individuals needs to be explored further. One study showed that the count for members of the order Methanobacteriales is increased in the gut of obese individuals relative to normal-weight individuals and those who have undergone a gastric bypass operation, although these archaea are still at least 10,000 times less abundant than total bacteria 72 . Another study found only a modest and statistically nonsignificant increase in the number of M. smithii cells in obese versus lean individuals 73 . Interestingly, the number of M. smithii cells in the microbiota is significantly elevated in patients with anorexia, possibly representing an adaptive response for maximal exploitation of the limited caloric diet of these individuals 73 . On the basis of the evidence from experimental animals discussed above, and the genomic and metabolic features of M. smithii in the human and mouse gut, this organism has been proposed as a potential key therapeutic target for reducing energy harvest in obese individuals and thereby treating this disease 69 .
Conclusions and perspectives
The advent of new molecular approaches to characterize the human microbiome has dramatically changed our appreciation of microbial diversity, although we are still far from understanding the complex hostmicroorganism and inter-microorganism interactions that either promote health or lead to disease. For at least some polymicrobial inflammatory diseases, the keystonepathogen hypothesis might shed light on the mechanisms governing the structure of microbial communities and how they instigate disease. There is now a substantial body of literature in support of a role for keystone pathogens that provoke inflammation by remodelling the microbiota. This can occur through direct effects on the microbiota (for example, altering transcriptional profiles), through indirect effects resulting from host modulation (for example, manipulation of host signalling, leading to impaired immunosurveillance) or, in principle, through both mechanisms.
One intriguing issue that requires further research is why the presence of a keystone pathogen (for example, P. gingivalis in the human periodontium or ETBF in the human colon) does not always lead to the conversion of a symbiotic microbiota to a dysbiotic one. P. gingivalis, for example, can Nature Reviews | Microbiology Thus, analysis of the current literature suggests that the keystone-pathogen concept is a plausible hypothesis. Bacteria might not be the only organisms capable of manipulating the commensal microbiota to cause disease. Recently, viruses have been shown to co-opt the intestinal commensal microbiota to promote viral pathogenesis 74, 75 . Further research is needed to identify keystone pathogens that fulfil the criteria of low relative abundance and a communitywide impact that involves host modulation and drives disease pathogenesis. A keystone pathogen is an agent that remodels the commensal microbiota into a dysbiotic state by causing disruption of host homeostasis. A keystone pathogen does not rely on already disrupted host homeostasis to cause disease, as has been proposed for 'pathobionts' , which are not necessarily low-abundance species and which promote chronic inflammatory pathology only in hosts with specific genetic or environmental alterations, such as a compromised immune system 76, 77 . Identifying the microbial species that act as stabilizing elements of symbiotic microbial communities (BOX 1) is equally important. Finally, perhaps the greatest challenge for the future will be the translation of findings from animal experiments to human medicine for the development of new diagnostic tools and treatment modalities targeting keystone pathogens in complex dysbiotic diseases.
Bacteroides thetaiotaomicron

Induction
Box 1 | Bacteroides thetaiotaomicron: a key stabilizer of symbiosis
Bacteroides thetaiotaomicron is an anaerobic symbiont in the distal human intestine and has an unusually large glycobiome (the repertoire of genes involved in the acquisition and metabolism of polysaccharides) 78 . This glycobiome enables B. thetaiotaomicron to turn to host polysaccharides when dietary polysaccharides become limited. B. thetaiotaomicron not only hydrolyses host-derived glycans but also proactively determines the type of glycans that are produced by gut epithelial cells 79, 80 . The induction of host-derived glycans by B. thetaiotaomicron might serve an adaptive function, creating a habitable niche for itself that other glycophiles could exploit, and thereby contributing to ecosystem stability and functional diversity (see the figure) . Another mechanism by which B. thetaiotaomicron might stabilize the microbial ecology towards a healthy host-microbiota relationship involves its ability to induce the antimicrobial peptide angiogenin, which kills opportunistic or pathogenic organisms but not B. thetaiotaomicron or other commensals 81 (see the figure) . Moreover, B. thetaiotaomicron inhibits the transcription of pro-inflammatory genes through peroxisome proliferator-activated receptor-γ (PPARγ)-dependent nuclear export of the nuclear factor-κB subunit p65 (REF. 82 ), thereby potentially resisting inflammatory changes that could destabilize the symbiotic microbiota (see the figure) . These unique features have prompted the characterization of B. thetaiotaomicron as a keystone species 83 .
In diametric opposition to a keystone pathogen, a low-abundance symbiont with a community-wide impact promoting a homeostatic relationship with the host could be considered as a keystone symbiont. Implicit in the keystone metaphor, however, is not only the principle of a high impact on the surrounding components of the community, but also the principle of a minority component -the keystone is only one of many stones in an arch. In this regard, B. thetaiotaomicron does not fulfil the low-abundance criterion, and its keystone status falls under the loose definition of the term 84, 85 .
